Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Series D
Biotech
Angitia raises $130M to advance bone-building bispecifics
Angitia's second mega-round in 14 months will support phase 2 and 3 clinical trials of three bone disease prospects.
Nick Paul Taylor
Feb 5, 2026 10:17am
Fierce Biotech Fundraising Tracker: Syneron, Atavistik & more
Dec 19, 2025 2:00pm
Artios Pharma widens clinical ambitions with $115M series D
Nov 17, 2025 8:00am
Synchron raises $200M to advance its brain-computer interface
Nov 7, 2025 5:20am
HistoSonics reels in $250M in funding months after sale
Oct 20, 2025 9:10am
Starry-eyed Star blazes forward with $125M funding boost
Sep 30, 2025 6:30am
